C.R. Bard, Inc. Product Pipeline Analysis

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

C.R. Bard, Inc. Product Pipeline Analysis
Published on January 2009

Report Summary


Summary

This report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The
report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary
end-points and trial results for products in development.

Scope

' Details of development stage by sector and equipment type.
' Pipeline products grouped by therapy area, development stage and trial phase.
' Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points
and trial results.
' Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
' Product updates covering estimated approval dates and estimated launch dates.
' Descriptions of novel technologies relating to pipeline products of the company.
' Patents and patent applications covered for the product.
' News updates on key events relating to the product and its development.

Reasons to buy

' A single source to fulfill competitor information relating to products in development.
' Identify pipeline products that are potential competitor to your product lines.
' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
' Access clinical trial information to map trial results and plan targeted marketing activities.
' Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product
pipelines.
' Identification of potential investment opportunities.
' Build up knowledge base for potential distribution and marketing partners.
' Helps avoid patent infringement.
' Timelines from concept to market lets you keep track of market potential build for a new product.
' Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Table of Content

1 Table of Contents 2
1.1 List of Tables 5

C.R. Bard, Inc. Product Pipeline Analysis Page 1/5


1.2 List of Figures 6
2 Company Snapshot 7
2.1 Key Information 7
2.2 Company Overview 7
3 C.R. Bard, Inc. Pipeline Products 8
3.1 C.R. Bard, Inc. Product Pipeline Analysis 8
3.1.1 C.R. Bard, Inc. Pipeline Products By Equipment Type 8
3.1.2 C.R. Bard, Inc. Pipeline Products By Development Stage 10
3.1.3 C.R. Bard, Inc. Pipeline Products By Therapy Area 10
3.1.4 C.R. Bard, Inc. Pipeline Products By Clinical Trials 11
3.2 VIVEXX Carotid Stent 12
3.2.1 Product Status 12
3.2.2 Product Description 12
3.2.3 Clinical Trials 12
3.2.4 Product Patent Details 13
3.3 Bard Pulsed RF Ablation System 14
3.4 BARD HD MESH Ablation System 16
3.5 BARD HD MESH Mapper Catheter 17
3.6 E-LUMINEXX Iliac Stent 18
3.7 RESTORe Suturing System 20
3.7.3 RESTORe Suturing SystemClinical Trials 1 20
3.7.4 RESTORe Suturing SystemClinical Trials 2 21
3.8 LifeStent FlexStar Stent 23
4 Recent Developments 24
4.1 Product News 24
4.1.1 Aug 20, 2008: C. R. Bard Inc. Published Clinical Study Results Of Agento I.C. Silver-Coated Endotracheal Tube 24
4.1.2 Jun 02, 2008: Edwards Lifesciences Corporation (EW) Receives Additional Questions From The FDA About The LifeStent
Product Line 24
4.1.3 Jan 14, 2008: Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard 24
4.1.4 Dec 07, 2007: Edwards Lifesciences To Sell LifeStent Product Line To Bard 24
4.1.5 Nov 08, 2007: Bard Receives Clearance To Market Agento IC Silver-Coated Endotracheal Tube 24
4.1.6 Oct 23, 2007: Edwards' Resilient Trial Demonstrates Statistically Superior Results For Treating Peripheral Arterial Disease In



The Leg 25
4.1.7 Oct 12, 2007: C.R. Bard Signs Agreement To Acquire LifeStent From Edwards Lifesciences Corporation 25
4.1.8 Jul 23, 2004: First Patient Treated In Clinical Trial Of Edwards LifeStent Self-Expanding Stent For Treating Peripheral Vascular
Disease 26
4.2 Product Approvals 26
4.2.1 Nov 08, 2007: Bard Receives Clearance To Market Agento IC Silver-Coated Endotracheal Tube 26
4.3 Clinical Trials 26
4.3.1 Aug 20, 2008: C. R. Bard Inc. Published Clinical Study Results Of Agento I.C. Silver-Coated Endotracheal Tube 26
4.3.2 Oct 23, 2007: Edwards' Resilient Trial Demonstrates Statistically Superior Results For Treating Peripheral Arterial Disease In
The Leg 27
4.3.3 Jul 23, 2004: First Patient Treated In Clinical Trial Of Edwards LifeStent Self-Expanding Stent For Treating Peripheral Vascular
Disease 27
5 Appendix 28
5.1 Methodology 28
5.1.1 Coverage 28
5.1.2 Secondary Research 29
5.1.3 Primary Research 29
5.1.4 Expert Panel Validation 30
5.2 Contact Us 30
5.3 About Global Markets Direct 30
5.4 Disclaimer 30

1.2 List of Figures
Figure 1: C.R. Bard, Inc. Pipeline Products By Equipment Type 8
Figure 2: C.R. Bard, Inc. Pipeline Products By Equipment Type 9
Figure 3: C.R. Bard, Inc. Pipeline Products By Clinical Trials 11
Figure 4: Global Markets Direct Methodology 28



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

Digital Copy--USD 750.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


C.R. Bard, Inc. Product Pipeline Analysis

Recommended

Recommended

More Related Content

More from ReportLinker.com

More from ReportLinker.com (20)

Recently uploaded

Recently uploaded (20)

C.R. Bard, Inc. Product Pipeline Analysis